Among the 12 genes of the ACEsig, CALCRL, a G-protein-coupled neuropeptide receptor, and HOPX, a transcription factor involving in regulating differentiation, have both been associated with a poorer prognosis across multiple AML cohorts [67–69]. The gene discussed is CALCRL; the disease is acute myeloid leukemia.